Publications dans lesquelles il/elle collabore avec URKO AGUIRRE LARRAKOETXEA (24)

2024

  1. Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer

    World journal of urology, Vol. 42, Núm. 1, pp. 141

2023

  1. Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?

    Clinica Chimica Acta, Vol. 542

2021

  1. Predictors of mortality of COVID-19 in the general population and nursing homes

    Internal and Emergency Medicine, Vol. 16, Núm. 6, pp. 1487-1496

2020

  1. Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease

    United European Gastroenterology Journal, Vol. 8, Núm. 9, pp. 1056-1066

  2. Tacrolimus induces short-term but not long-term clinical response in inflammatory bowel disease

    Alimentary Pharmacology and Therapeutics, Vol. 51, Núm. 9, pp. 870-879

2018

  1. Characteristics and Progression of Preclinical Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 16, Núm. 9, pp. 1459-1466

2016

  1. Determinants of change in physical activity during moderate-to-severe copd exacerbation

    International Journal of COPD, Vol. 11, pp. 251-261

  2. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

  3. Outcomes of a telemonitoring-based program (telEPOC) in frequently hospitalized COPD patients

    International Journal of COPD, Vol. 11, Núm. 1, pp. 2919-2930

  4. Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease

    Revista Espanola de Enfermedades Digestivas, Vol. 108, Núm. 9, pp. 550-557

2015

  1. Association between C-reactive protein and the progression of the abdominal aortic aneurysm

    Angiologia, Vol. 67, Núm. 3, pp. 193-199

2014

  1. Clinical, electrophysiological and magnetic resonance findings in a family with hereditary neuropathy with liability to pressure palsies caused by a novel PMP22 mutation

    Neuromuscular Disorders, Vol. 24, Núm. 1, pp. 56-62

  2. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

  3. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments

    BMC Medicine, Vol. 12, Núm. 1

  4. Predictors of hospital admission two months after emergency department evaluation of COPD exacerbation

    Respiration, Vol. 88, Núm. 4, pp. 298-306

2013

  1. Predictors of hospital admission in exacerbations of chronic obstructive pulmonary disease

    International Journal of Tuberculosis and Lung Disease, Vol. 17, Núm. 12

  2. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

2011

  1. Estudio de contactos en niños y adolescentes usando el QuantiFERON-TB ® gold in-tube

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 74, Núm. 6, pp. 363-370